Intercept Pharmaceuticals Inc (ICPT)

NASDAQ
17.04
+1.18(+7.44%)
After Hours
17.04
0.00(0.00%)
- Real-time Data
  • Volume:
    1,023,401
  • Bid/Ask:
    15.86/17.04
  • Day's Range:
    15.66 - 17.08

ICPT Overview

Prev. Close
15.86
Day's Range
15.66-17.08
Revenue
354.34M
Open
15.94
52 wk Range
11.6-38.89
EPS
-3.25
Volume
1,023,401
Market Cap
503.48M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
789,077
P/E Ratio
-
Beta
1.43
1-Year Change
-53.46%
Shares Outstanding
29,546,974
Next Earnings Date
24 Feb 2022
What is your sentiment on Intercept Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Intercept Pharmaceuticals Inc Company Profile

Employees
498

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. Its lead products candidate is the Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid in adults. The company is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis (NASH); and other product candidates in various stages of clinical and preclinical development. It has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. The company markets its products through an internal commercial organization, a contract sales organization, and third-party distributors. Intercept Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in New York, New York.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellSell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.